Cell-Extrinsic Effects of Tumor ER Stress Imprint Myeloid Dendritic Cells and Impair CD8+ T Cell Priming

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Mahadevan, Navin R ^a   Anufreichik, Veronika ^a   Rodvold, Jeffrey J ^a   Chiu, Kevin T ^a   Sepulveda, Homero ^b   Zanetti, Maurizio ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b BD BIOSCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; BYSTANDER EFFECT; CD8+ T LYMPHOCYTE; CELL POLARITY; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE PRODUCTION; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; IN VIVO STUDY; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; UNFOLDED PROTEIN RESPONSE; UPREGULATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CROSS-PRIMING; DENDRITIC CELLS; ENDOPLASMIC RETICULUM STRESS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MELANOMA, EXPERIMENTAL; MICE; NEOPLASMS; TUMOR BURDEN;

EID: 84871265006     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051845     Document Type: Article

References (65)

1. Harding HP, Calfon M, Urano F, Novoa I, Ron D, (2002) Transcriptional and translational control in the Mammalian unfolded protein response. Annu Rev Cell Dev Biol 18: 575-599.
2. Walter P, Ron D, (2011) The unfolded protein response: from stress pathway to homeostatic regulation. Science 334: 1081-1086.
3. Todd DJ, Lee AH, Glimcher LH, (2008) The endoplasmic reticulum stress response in immunity and autoimmunity. Nat Rev Immunol 8: 663-674.
4. Goodall JC, Wu C, Zhang Y, McNeill L, Ellis L, et al. (2010) Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression. Proc Natl Acad Sci U S A 107: 17698-17703.
5. Spiotto MT, Banh A, Papandreou I, Cao H, Galvez MG, et al. (2010) Imaging the unfolded protein response in primary tumors reveals microenvironments with metabolic variations that predict tumor growth. Cancer Res 70: 78-88.
6. Fu Y, Wey S, Wang M, Ye R, Liao CP, et al. (2008) Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium. Proc Natl Acad Sci U S A 105: 19444-19449.
7. Romero-Ramirez L, Cao H, Nelson D, Hammond E, Lee AH, et al. (2004) XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res 64: 5943-5947.
8. Bi M, Naczki C, Koritzinsky M, Fels D, Blais J, et al. (2005) ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J 24: 3470-3481.
9. Feldman DE, Chauhan V, Koong AC, (2005) The unfolded protein response: a novel component of the hypoxic stress response in tumors. Mol Cancer Res 3: 597-605.
10. Zhang K, Kaufman RJ, (2008) From endoplasmic-reticulum stress to the inflammatory response. Nature 454: 455-462.
11. Mahadevan NR, Zanetti M, (2011) Tumor stress inside out: Cell-extrinsic effects of the unfolded protein response in tumor cells modulate the immunological landscape of the tumor microenvironment. J Immunol 187: 4403-4409.
12. Jamora C, Dennert G, Lee AS, (1996) Inhibition of tumor progression by suppression of stress protein GRP78/BiP induction in fibrosarcoma B/C10ME. Proc Natl Acad Sci U S A 93: 7690-7694.
13. Luo B, Lee AS (2012) The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies. Oncogene.
14. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V, (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12: 253-268.
15. Ostrand-Rosenberg S, Sinha P, (2009) Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 182: 4499-4506.
16. Norian LA, Rodriguez PC, O'Mara LA, Zabaleta J, Ochoa AC, et al. (2009) Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism. Cancer Res 69: 3086-3094.
17. Liu Q, Zhang C, Sun A, Zheng Y, Wang L, et al. (2009) Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I. J Immunol. 182: 6207-6216.
18. Mahadevan NR, Rodvold J, Sepulveda H, Rossi S, Drew AF, et al. (2011) Transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells. Proc Natl Acad Sci U S A 108: 6561-6566.
19. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, et al. (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296.
20. Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, et al. (2006) IL-23 promotes tumour incidence and growth. Nature 442: 461-465.
21. Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, et al. (2009) Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457: 102-106.
22. Bronte V, Zanovello P, (2005) Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 5: 641-654.
23. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A, (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555.
24. Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, et al. (2000) Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192: 1027-1034.
25. Yewdell JW, Norbury CC, Bennink JR, (1999) Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines. Advances in Immunology 73: 1-77.
26. Marzo AL, Lake RA, Lo D, Sherman L, McWilliam A, et al. (1999) Tumor antigens are constitutively presented in the draining lymph nodes. J Immunol 162: 5838-5845.
27. Kurts C, Robinson BW, Knolle PA, (2010) Cross-priming in health and disease. Nat Rev Immunol 10: 403-414.
28. Porgador A, Yewdell JW, Deng Y, Bennink JR, Germain RN, (1997) Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6: 715-726.
29. Clarke SR, Barnden M, Kurts C, Carbone FR, Miller JF, et al. (2000) Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol Cell Biol 78: 110-117.
30. Beverly B, Kang SM, Lenardo MJ, Schwartz RH, (1992) Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int Immunol 4: 661-671.
31. Huard B, Gaulard P, Faure F, Hercend T, Triebel F, (1994) Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand. Immunogenetics 39: 213-217.
32. Grosso JF, Kelleher CC, Harris TJ, Maris CH, Hipkiss EL, et al. (2007) LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems. J Clin Invest 117: 3383-3392.
33. Becker JC, Vetter CS, Schrama D, Brocker EB, thor Straten P, (2000) Differential expression of CD28 and CD94/NKG2 on T cells with identical TCR beta variable regions in primary melanoma and sentinel lymph node. Eur J Immunol 30: 3699-3706.
34. Kruger K, Buning C, Schriever F, (2001) Activated T lymphocytes bind in situ to stromal tissue of colon carcinoma but lack adhesion to tumor cells. Eur J Immunol 31: 138-145.
35. Prehn RT, (1972) The immune reaction as a stimulator of tumor growth. Science 176: 170-171.
36. Redmond WL, Gough MJ, Charbonneau B, Ratliff TL, Weinberg AD, (2007) Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist. J Immunol 179: 7244-7253.
37. Ma Y, Hendershot LM, (2004) The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer 4: 966-977.
38. Blais JD, Addison CL, Edge R, Falls T, Zhao H, et al. (2006) Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress. Mol Cell Biol 26: 9517-9532.
39. Pereira ER, Liao N, Neale GA, Hendershot LM (2010) Transcriptional and post-transcriptional regulation of proangiogenic factors by the unfolded protein response. PLoS One 5.
40. Wang HC, Huang W, Lai MD, Su IJ, (2006) Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci 97: 683-688.
41. Hotamisligil GS, (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140: 900-917.
42. Rodriguez PC, Hernandez CP, Quiceno D, Dubinett SM, Zabaleta J, et al. (2005) Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J Exp Med 202: 931-939.
43. Steinman RM, Hawiger D, Nussenzweig MC, (2003) Tolerogenic dendritic cells. Annu Rev Immunol 21: 685-711.
44. Steinman RM, Nussenzweig MC, (2002) Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A 99: 351-358.
45. Caron E, Vincent K, Fortier MH, Laverdure JP, Bramoulle A, et al. (2011) The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol Syst Biol 7: 533.
46. Ortmann B, Copeman J, Lehner PJ, Sadasivan B, Herberg JA, et al. (1997) A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 277: 1306-1309.
47. Park B, Kim Y, Shin J, Lee S, Cho K, et al. (2004) Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity 20: 71-85.
48. Pellicciotta I, Cortez-Gonzalez X, Sasik R, Reiter Y, Hardiman G, et al. (2008) Presentation of telomerase reverse transcriptase, a self-tumor antigen, is down-regulated by histone deacetylase inhibition. Cancer Res 68: 8085-8093.
49. Granados DP, Tanguay PL, Hardy MP, Caron E, de Verteuil D, et al. (2009) ER stress affects processing of MHC class I-associated peptides. BMC Immunol 10: 10.
50. Nagaraj S, Gupta K, Pisarev V, Kinarsky L, Sherman S, et al. (2007) Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med 13: 828-835.
51. Bretscher P, Cohn M, (1970) A theory of self-nonself discrimination. Science 169: 1042-1049.
52. Schwartz RH, (2003) T cell anergy. Annu Rev Immunol 21: 305-334.
53. Schwartz RH, (1990) A cell culture model for T lymphocyte clonal anergy. Science 248: 1349-1356.
54. Wells AD, Walsh MC, Bluestone JA, Turka LA, (2001) Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J Clin Invest 108: 895-903.
55. Deeths MJ, Kedl RM, Mescher MF, (1999) CD8+ T cells become nonresponsive (anergic) following activation in the presence of costimulation. J Immunol 163: 102-110.
56. Filaci G, Fenoglio D, Fravega M, Ansaldo G, Borgonovo G, et al. (2007) CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers. J Immunol 179: 4323-4334.
57. Mahic M, Henjum K, Yaqub S, Bjornbeth BA, Torgersen KM, et al. (2008) Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation. Eur J Immunol 38: 640-646.
58. Franco A, Almanza G, Burns JC, Wheeler M, Zanetti M, (2010) Endoplasmic reticulum stress drives a regulatory phenotype in human T-cell clones. Cell Immunol 266: 1-6.
59. Reimold AM, Iwakoshi NN, Manis J, Vallabhajosyula P, Szomolanyi-Tsuda E, et al. (2001) Plasma cell differentiation requires the transcription factor XBP-1. Nature 412: 300-307.
60. Iwakoshi NN, Pypaert M, Glimcher LH, (2007) The transcription factor XBP-1 is essential for the development and survival of dendritic cells. J Exp Med 204: 2267-2275.
61. Bensinger SJ, Walsh PT, Zhang J, Carroll M, Parsons R, et al. (2004) Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J Immunol 172: 5287-5296.
62. Kamimura D, Bevan MJ, (2008) Endoplasmic reticulum stress regulator XBP-1 contributes to effector CD8+ T cell differentiation during acute infection. J Immunol 181: 5433-5441.
63. Richardson CE, Kooistra T, Kim DH, (2010) An essential role for XBP-1 in host protection against immune activation in C. elegans. Nature 463: 1092-1095.
64. Daniel C, von Boehmer H, (2011) Extrathymic generation of regulatory T cells-chances and challenges for prevention of autoimmune disease. Adv Immunol 112: 177-213.
65. Healy SJ, Gorman AM, Mousavi-Shafaei P, Gupta S, Samali A, (2009) Targeting the endoplasmic reticulum-stress response as an anticancer strategy. Eur J Pharmacol 625: 234-246.